Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,976,137 papers from all fields of science
Search
Sign In
Create Free Account
E 643
Known as:
E-643
, E643
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
bunazosin
bunazosin hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Antihypertensive effect of E-643, a new alpha-adrenergic blocking agent
Terukazu Kawasaki
,
K. Uezono
,
+4 authors
Teruo Omae
European Journal of Clinical Pharmacology
2004
Corpus ID: 23690655
SummaryTo determine whether E-643, a new α-blocking agent, would reduce the blood pressure, regardless of the posture, a 1 mg…
Expand
1986
1986
Acute systemic and regional hemodynamic effects of alpha 1-adrenoceptor blockade in conscious spontaneously hypertensive rats.
M. Nakai
,
J. Yamamoto
,
Y. Matsui
Clinical and Experimental Hypertension Part A…
1986
Corpus ID: 12840563
The acute hemodynamic effect of the selective alpha1-antagonist, 2-[4-(n-butyryl)-homopiperazine-1-y1]-4-amino-6,7-dimethoxy…
Expand
1985
1985
[Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine…
M. Minami
,
H. Togashi
,
+7 authors
H. Saito
[Hokkaido igaku zasshi] The Hokkaido journal of…
1985
Corpus ID: 22969012
Present study was undertaken to elucidate the effects of E-643, on blood pressure, urinary electrolyte (U-Na, U-K) and…
Expand
1982
1982
Characteristics of [3H]E-643-binding to alpha adrenoceptors.
F. Hata
,
E. Kondo
,
S. Kondo
,
K. Kagawa
,
H. Ishida
Japanese Journal of Pharmacology
1982
Corpus ID: 30075063
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with…
Expand
Highly Cited
1981
Highly Cited
1981
Comparison of pre- and postsynaptic alpha-adrenoceptor blocking effects of E-643 in the isolated vas deferens of the rat.
Tadao Shoji
Japanese Journal of Pharmacology
1981
Corpus ID: 18935434
Effectiveness of E-643, a newly developed alpha-blocker, and four alpha-antagonists in blocking pre- and postsynaptic alpha…
Expand
1981
1981
Chronotropic and inotropic effects of 3 kinds of alpha-adrenergic blockers on the isolated dog atria.
S. Chiba
,
Y. Furukawa
,
H. Watanabe
Japanese Heart Journal
1981
Corpus ID: 5770096
Using the isolated and blood-perfused dog atrial preparation, chronotropic and inotropic responses to 3 kinds of alpha-adrenergic…
Expand
1980
1980
alpha-Adrenoceptor blocking properties of a new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-yl]-4-amino-6,7-dimethoxyquinazoline (E-643).
T. Shoji
,
Y. Daiku
,
T. Igarashi
Japanese Journal of Pharmacology
1980
Corpus ID: 26307854
Postsynaptic alpha-receptor blocking properties of E-643 were studied in vivo and in vitro and compared with these same…
Expand
1980
1980
Effects of alpha blockers on blood pressure and on the Ca-contracture of cat aortic strips.
K. Hoshi
,
S. Fujino
Japanese Journal of Pharmacology
1980
Corpus ID: 27306599
To further clarify the hypotensive mechanism of adrenergic alpha blockers, effects of several alpha blockers on systemic blood…
Expand
1980
1980
The potentiating effect of an alpha-adrenergic blocking agent (E-643) on the action of bronchodilators.
S. Kitamura
,
Y. Ishihara
,
H. Yotsumoto
,
K. Kosaka
Arzneimittel-Forschung
1980
Corpus ID: 36561262
The effect of 2-[N-(n-butyloyl)homopiperazin-N'-yl]-4-amino-6,7-dimethoxy quinazoline hydrochloride (E-643), a new alpha…
Expand
1977
1977
Antihypertensive effect of combined treatment with alpha- and beta-adrenergic blockers in the spontaneously hypertensive rat.
T. Igarashi
,
Y. Nakajima
,
S. Ohtake
Japanese circulation journal
1977
Corpus ID: 30167895
Using a continuous systolic monitor, effects of oral administration of three alpha-adrenergic blockers, i.e. phenoxybenzamine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE